views: 323
Information
Professor
Sign in to view more
Experience
Sign in to view more
Education
Sign in to view more
Bio
Professor Tom Davis is a leading polymer scientist/nanotechnologist with a proven performance in producing highly influential research. This is exemplified by his presence in the latest ISI most highly cited listing, covering his performance over the last decade placing him as the most cited polymer scientist and/or nanotechnologist in Australia. He has published more than 360 refereed papers, with more than 36 publications cited 100+ times, and 115 publications cited 50+ times (ISI). He has held two senior ARC Fellowships: an Australian Professorial Fellowship and an Australian Federation Fellowship. His scientific contributions have embraced polymerization kinetics, nanostructured films, nanoparticles, protein conjugates, nanoparticle enhanced bio-imaging, gene delivery and targeted therapeutics. In recent years Davis has been awarded ARC Discovery grants to work on novel MRI contrast agents (iron oxide nanoparticles and gadolinium bound by macromolecular ligands) and he holds an ANSTO grant with PI Greguric to synthesise macromolecular ligands for novel PET agents. Davis also has significant experience in developing novel chemistry for bioconjugation reactions to proteins, peptides and DNA. Davis has worked closely with the Children's Cancer Institute on drug and gene delivery (CI Kavallaris) using novel biodegradable nanoparticle systems.
His move to Monash in 2013 has occurred because of a desire to drive a step-change in the field of nanomedicine development, and the realization that this is best achieved in a research environment where the best polymer scientists can interact, on a day-today basis with highly committed and highly experienced drug discovery biologists and drug development scientists. Tom is Professor of Polymer Nanotechnology. This is the inaugural Professorial Appointment under the banner of the Monash-Warwick University Alliance. The position is based at the Monash Institute of Pharmaceutical Sciences (MIPS) (80%) and the Department of Chemistry at the University of Warwick, UK (20%). The Monash-Warwick Alliance has the capacity to break new ground for Australian scientific as an internationalized model of collaborative research. The environment at MIPS, in conjunction with arguably the leading polymer science group in the UK at Warwick, is a unique opportunity to develop an internationally leading presence at the interface of polymer science and delivery technology.
His move to Monash in 2013 has occurred because of a desire to drive a step-change in the field of nanomedicine development, and the realization that this is best achieved in a research environment where the best polymer scientists can interact, on a day-today basis with highly committed and highly experienced drug discovery biologists and drug development scientists. Tom is Professor of Polymer Nanotechnology. This is the inaugural Professorial Appointment under the banner of the Monash-Warwick University Alliance. The position is based at the Monash Institute of Pharmaceutical Sciences (MIPS) (80%) and the Department of Chemistry at the University of Warwick, UK (20%). The Monash-Warwick Alliance has the capacity to break new ground for Australian scientific as an internationalized model of collaborative research. The environment at MIPS, in conjunction with arguably the leading polymer science group in the UK at Warwick, is a unique opportunity to develop an internationally leading presence at the interface of polymer science and delivery technology.
Research Interests
Papers
Sort
By YearBy Citation
Add Paper

View All
Ego Network
D-Core
Co-Author
Author Statistics
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn